Author

Sunayana Mitra

Massachusetts General HospitalPrimary ORCID profile (0000-0002-9694-764X · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Sunayana MitraiD2 papers · Michigan State University

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Christiano R. R. AlvesiD· 2 shared Leillani L. HaiD· 2 shared Becky Fillingham· 1 shared Benjamin P. KleinstiveriD· 1 shared C.K. Fong· 1 shared Casey A. MaguireiD· 1 shared Christian Lacks Lino CardenasiD· 1 shared Claire E. ShamberiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 38 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Christiano R. R. AlvesORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Circulating Tau Profiles in Pediatric and Adult Patients with Spinal Muscular Atrophy

Leillani L. Ha, Sunayana Mitra, Doreen T. Ho, Becky Fillingham, James D. Berry, Kathryn J. Swoboda, Christiano R. R. Alves

The paper measures circulating Tau and phosphorylated Tau profiles in SMA patients across different age groups and treatments, finding distinct alterations in adults and transient increases after gene therapy in infants.

Journal of Neurology · Jul 17, 2026Peer-reviewedGenetic & Genomic Medicine

In vivo Treatment of a Severe Vascular Disease via a Bespoke CRISPR-Cas9 Base Editor

Christiano R. R. Alves, Sabyasachi Das, Vijai Krishnan, Leillani L. Ha, Lauren R. Fox, Hannah E. Stutzman, Claire E. Shamber, Pazhanichamy Kalailingam, Siobhan McCarthy, Christian Lacks Lino Cardenas, C.K. Fong, Takahiko Imai, Sunayana Mitra, Shuqi Yun, Rachael K. Wood, , Patricia Leonor Musolino

This paper develops a customized CRISPR-Cas9 base editor to correct the ACTA2 R179H mutation in a mouse model of MSMDS, improving survival and rescuing vascular and neurological phenotypes.

Nature Biomedical Engineering · Sep 11, 2025Peer-reviewedBioengineering